Evidence map›Paper›PMID 33191334›Full record

ArticleThe Journal of veterinary medical science2021

Antifungal drugs-low-susceptibility in Aspergillus flavus isolated from a captively reared Okinawa rail (Hypotaenidia okinawae).

Rui Kano, Meika Tsunoi, Yumiko Nakaya, Takashi Nagamine, Koji Ono

Open access · diamondAbstract read
In one paragraph

Article in The Journal of veterinary medical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Azole resistance inFrontiers in veterinary science · 2025
    Pooled it
  2. Article
  3. Identification ofFrontiers in veterinary science · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rui KanoDepartment of Veterinary Dermatology, Nihon University College of Bioresource, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan.
Meika TsunoiDepartment of Veterinary Dermatology, Nihon University College of Bioresource, 1866 Kameino, Fujisawa, Kanagawa 252-0880, Japan.
Yumiko NakayaOkinawa Wildlife Federation, 308 Maehara, Uruma, Okinawa 904-2235, Japan.
Takashi NagamineOkinawa Wildlife Federation, 308 Maehara, Uruma, Okinawa 904-2235, Japan.
Koji OnoYambaru Wildlife Conservation Center, Ministry of the Environment, 1-15-15 Higawa, Naha, Okinawa 900-0022, Japan.
Nihon University · JPOkinawa Prefecture · JPMinistry of the Environment · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A four-month old female Okinawa rail (Hypotaenidia okinawae) presented with respiratory distress. Despite antifungal treatment with voriconazole (VRZ), micafungin (MCF), and itraconazole (ITZ), respiratory distress did not improve and the bird died 167 days after initiating treatment. Necropsy revealed multifocal pyogranulomatous necrotic nodular lesions with numerous whitish-green fungal hyphae in the left air sac. Aspergillus flavus was isolated from the left air sac lesion. Antifungal susceptibility tests indicated that the isolate showed low susceptibility to amphotericin B (AMB), fluconazole (FLZ), VRZ and MCF.

Indexed as

Antifungal AgentsPharmaceutical PreparationsAnimalsAspergillus flavusBirdsFemaleItraconazoleMicrobial Sensitivity TestsAntifungal AgentsItraconazolePharmaceutical Preparationsantifungal susceptibility testsAspergillus flavusavian aspergillosislow-susceptibilityOkinawa rail

Identifiers

PMID33191334
PMCPMC7870398
OpenAlexW3104214945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.